Trial intelligence / Profile preview

DIOS: DP-R206 vs Bonvia in postmenopausal women with osteoporosis

KCT0000415Phase 3Recruiting

Sponsor
Dream Pharma
Start
Jan 2012
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 3 trial of ibandronate + vitamin d in osteoporosis, sponsored by Dream Pharma. Started Jan 2012; status: recruiting.

02

Drugs

ibandronate + vitamin d
03

Conditions

osteoporosis

Beyond the preview

Go deeper on KCT0000415.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on KCT0000415.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call